The FDA issued a request to healthcare professionals to include a warning or deny prescription of Multaq to patients who suffer from Permanent Atrial Fibrillation and they cannot or do not choose to convert into normal sinus rhythm

Originally posted here: 
Multaq Is Risky, Says FDA; Causes Cardiovascular problems or even Death